'For Novo Nordisk, I do not worry a lot about tariffs:' CEO Lars Jørgensen
Tris to ask for approval of dual-acting pain drug
Abbott’s brain stimulation trial for depression kicks off at Mount Sinai
NICE agrees to look again at Alzheimer's drug Leqembi
*please scroll down for all the latest news*
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
Tris to ask for approval of dual-acting pain drug
Abbott’s brain stimulation trial for depression kicks off at Mount Sinai
NICE agrees to look again at Alzheimer's drug Leqembi
*please scroll down for all the latest news*
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud